Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-02

Clinical Trial Update: Effect of 10-day Overnight Hypoxia Treatment on Whole Body Insulin Sensitivity (SLEEP HIGH Study) [EARLY_Phase 1]

View source ↗

Summary

Phase 1 trial titled SLEEP HIGH tests whether 10 days of overnight hypoxia improves whole-body insulin sensitivity; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Overnight hypoxia treatment (SLEEP HIGH)

Snippet

Sponsor: Pennington Biomedical Research Center | Conditions: Insulin Resistance | EARLY_Phase 1 | Status: COMPLETED